Table 4. Characteristics participants reporting prior COVID-19 by SARS-CoV-2 serostatus (n = 179).
| SARS-CoV-2 Seropositive | SARS-CoV-2 Seronegative | Adjusted Odds Ratio | ||||
|---|---|---|---|---|---|---|
| n | (%) | n | (%) | aOR | (95% CI) | |
| Hospitalized due to COVID-19 | ||||||
| No | 100 | (78.7) | 39 | (79.6) | 1 | (ref) |
| Yes | 27 | (21.3) | 10 | (20.4) | 0.63 | (0.24–1.66) |
| Months between diagnosis and enrollment | ||||||
| <6 months | 20 | (18.3) | 13 | (31.0) | 1 | (ref) |
| 6–11 months | 41 | (37.6) | 12 | (28.6) | 1.02 | (0.37–2.79) |
| ≥12 months | 48 | (44.0) | 17 | (40.5) | 0.41 | (0.11–1.51) |
| COVID-19 vaccination† | ||||||
| No | 54 | (41.9) | 37 | (75.5) | 1 | (ref) |
| Yes | 75 | (58.1) | 12 | (24.5) | 4.11 | (1.80–9.41)* |
aOR = adjusted odds ratio (adjusted for district and enrollment month); CI = confidence interval
†Received ≥1 doses of any COVID-19 vaccine.
*p<0.05